Celldex Therapeutics
Developing antibodies that address devastating diseases for which available treatments are inadequate. Learn more
Launch date
Employees
Market cap
AUD4.3b
Enterprise valuation
AUD3.0b (Public information from Sep 2024)
Share price
$41.16 CLDX
Hampton Township Pennsylvania (HQ)
Authorizing premium user...